Thus, routine use of the test may lead to inequitable access to the healthcare. Overall, the Guideline Development Group (GDG) concluded that the benefits of using AST to guide the therapy can outweigh the potential adverse effects and that its use should be encouraged at least in people on...
Eisai’s Corporate Concept is to “give first thought to patients and the people in the daily living domain, and [to] increase the benefits that healthcare provides.” Under this Concept [also known ...
Dr. Hui Zhou, Senior Vice President of Innovent, stated:"Given the clinically demonstrated benefits of taletrectinib in the TRUST-I trial, we are pleased to see the second NDA accepted by the NMPA of China. We wil...
today announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial. These analyses reinforce the proven survival benefits of BAVENCIO® (avelumab) in the first-line maintenance setting for patients with locally advanced or...
Median OS was 15.6 months in the sugemalimabtreatment group versus 12.6 months in the placebo group, with an HR of 0.75 (95%CI, 0.61-0.92), P=0.0060. Subgroup analyses has demonstrated clinical benefits across all pre-defined subgroups, inclu...
Classifying breast cancer based on molecular subtypes is a growing clinical practice that warrants benefits [2,20,21] and it is primarily conducted in the West [22,23]. There is limited information on this practice in the Asian population [24]. Breast cancer incidence in the Asian population ...
4,10 A number of these triplets have been approved by the European Medicines Agency (EMA) in recent years (i.e., IsaKd; DKd; DPomd) and offer improved survival benefits in Len-refractory patients, thought their use was limited in our study (received in <2% of patients) due to the ...
(Table 2). The unit cost of the antimalarial varies by dose and was calculated according to the number of cases occurring in each dose group, based on age-specific clinical incidence from the model and population age structure. All costs and health benefits were discounted annually at a rate...
Obstructive sleep apnoea (OSA) is a common disease that benefits from early treatment and patient support in order to prevent secondary illnesses. This study assesses the capability of the large language model (LLM) ChatGPT-4o to offer patient support regarding first line positive airway pressure ...
BioLineRx Ltd. announced encouraging data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination clinical trial evaluating the company's CXCR4 inhibitor motixafortide, the PD-1 inhibitor...